Haemonetics (HAE) Revenue & Revenue Breakdown

Overview ForecastOwnership Financials Chart Transcripts

Haemonetics Revenue Highlights

Latest Revenue (Y)

$1.33B

Latest Revenue (Q)

$338.97M

Main Segment (Y)

Hospital

Main Geography (Y)

UNITED STATES

Haemonetics Revenue by Period

Haemonetics Revenue by Year

Date	Revenue	Change
2026-03-28	$1.33B	-1.97%
2025-03-29	$1.36B	3.95%
2024-03-31	$1.31B	12.01%
2023-03-31	$1.17B	17.67%
2022-03-31	$993.20M	14.10%
2021-03-31	$870.46M	-11.94%
2020-03-31	$988.48M	2.16%
2019-03-31	$967.58M	7.04%
2018-03-31	$903.92M	2.01%
2017-03-31	$886.12M	-2.50%
2016-03-31	$908.83M	-0.17%
2015-03-31	$910.37M	-3.00%
2014-03-31	$938.51M	5.22%
2013-03-31	$891.99M	22.55%
2012-03-31	$727.84M	7.56%
2011-03-31	$676.69M	4.84%
2010-03-31	$645.43M	7.95%
2009-03-31	$597.88M	15.77%
2008-03-31	$516.44M	14.86%
2007-03-31	$449.61M	7.12%
2006-03-31	$419.73M	9.42%
2005-03-31	$383.60M	5.32%
2004-03-31	$364.23M	8.09%
2003-03-31	$336.96M	5.31%
2002-03-31	$319.97M	8.88%
2001-03-31	$293.86M	5.73%
2000-03-31	$277.92M	-1.48%
1999-03-31	$282.10M	-1.29%
1998-03-31	$285.80M	-7.75%
1997-03-31	$309.80M	11.36%
1996-03-30	$278.20M	6.02%
1995-03-31	$262.40M	5.64%
1994-03-31	$248.40M	-

Haemonetics generated $1.33B in revenue during NA 2026, up -1.97% compared to the previous quarter, and up 153.25% compared to the same period a year ago.

Haemonetics Revenue by Quarter

Date	Revenue	Change
2025-12-27	$338.97M	3.56%
2025-09-27	$327.31M	1.84%
2025-06-28	$321.39M	-2.78%
2025-03-31	$330.60M	-5.15%
2024-12-28	$348.54M	0.88%
2024-09-28	$345.51M	2.78%
2024-06-29	$336.17M	-2.07%
2024-03-31	$343.29M	2.09%
2023-12-30	$336.25M	5.68%
2023-09-30	$318.18M	2.20%
2023-07-01	$311.33M	2.27%
2023-03-31	$304.42M	-0.29%
2022-12-31	$305.30M	2.63%
2022-10-01	$297.49M	13.78%
2022-07-02	$261.46M	-1.34%
2022-03-31	$265.00M	2.01%
2022-01-01	$259.77M	8.28%
2021-10-02	$239.90M	4.97%
2021-07-03	$228.53M	1.55%
2021-03-31	$225.03M	-6.38%
2020-12-26	$240.37M	14.74%
2020-09-26	$209.49M	7.11%
2020-06-27	$195.58M	-17.99%
2020-03-31	$238.49M	-7.91%
2019-12-28	$258.97M	2.54%
2019-09-28	$252.57M	5.92%
2019-06-29	$238.45M	-4.35%
2019-03-31	$249.29M	0.78%
2018-12-29	$247.36M	2.39%
2018-09-29	$241.58M	5.33%
2018-06-30	$229.35M	-1.80%
2018-03-31	$233.55M	-0.21%
2017-12-30	$234.04M	3.85%
2017-09-30	$225.38M	6.84%
2017-07-01	$210.95M	-7.50%
2017-04-01	$228.07M	0.10%
2016-12-31	$227.84M	3.45%
2016-10-01	$220.25M	4.90%
2016-07-02	$209.96M	-13.66%
2016-04-02	$243.19M	4.20%
2015-12-26	$233.38M	6.23%
2015-09-26	$219.69M	2.94%
2015-06-27	$213.41M	-5.77%
2015-03-28	$226.48M	-2.31%
2014-12-27	$231.83M	1.87%
2014-09-27	$227.58M	1.38%
2014-06-28	$224.49M	-6.89%
2014-03-29	$241.09M	-0.42%
2013-12-28	$242.12M	2.70%
2013-09-28	$235.75M	7.38%
2013-06-29	$219.54M	-12.16%
2013-03-30	$249.94M	1.03%
2012-12-29	$247.40M	13.39%
2012-09-29	$218.18M	23.63%
2012-06-30	$176.47M	-5.46%
2012-03-31	$186.67M	-2.35%
2011-12-31	$191.16M	6.53%
2011-10-01	$179.44M	5.20%
2011-07-02	$170.57M	0.32%
2011-04-02	$170.03M	-3.82%
2011-01-01	$176.79M	5.97%
2010-10-02	$166.83M	2.33%
2010-07-03	$163.04M	-3.59%
2010-04-03	$169.10M	2.38%
2009-12-26	$165.17M	5.16%
2009-09-26	$157.07M	1.94%
2009-06-27	$154.09M	1.11%
2009-03-28	$152.40M	-1.96%
2008-12-27	$155.45M	6.53%
2008-09-27	$145.92M	1.25%
2008-06-28	$144.12M	3.88%
2008-03-29	$138.74M	-

Haemonetics generated $338.97M in revenue during Q3 2026, up 3.56% compared to the previous quarter, and up 98.11% compared to the same period a year ago.

Haemonetics Revenue Breakdown

Haemonetics Revenue Breakdown by Product

Annual Revenue by Product

Product/Service	Mar 26	Mar 25	Mar 24	Apr 23	Apr 22
Interventional Technologies, Hospital	$234.01M	-	-	-	-
Whole Blood, Blood Center	$406.00K	-	-	-	-
Apheresis, Blood Center	$220.86M	-	-	-	-
Plasma	$524.46M	$535.43M	$563.73M	$427.61M	-
Blood Center	$221.27M	$261.12M	$226.82M	$236.16M	-
Hospital	$588.30M	$564.27M	$378.11M	$329.43M	-
Hemostasis Management, Hospital	$354.30M	-	-	-	-
Service	-	-	$21.63M	$21.42M	$20.81M

Haemonetics's latest annual revenue breakdown by segment (product or service), as of Mar 26: Hospital (27.44%), Plasma (24.47%), Hemostasis Management, Hospital (16.53%), Interventional Technologies, Hospital (10.92%), Blood Center (10.32%), Apheresis, Blood Center (10.30%), and Whole Blood, Blood Center (0.02%).

Quarterly Revenue by Product

Product/Service	Mar 26	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Mar 24	Dec 23	Sep 23	Jul 23	Dec 22	Oct 22	Jul 22	Jan 22	Oct 21	Jul 21	Apr 21	Dec 20	Sep 20
Apheresis, Blood Center	$108.24M	$56.56M	$56.06M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Hospital	$159.65M	$143.50M	$145.50M	$139.66M	$147.23M	$144.25M	$138.38M	-	-	-	-	-	-	-	-	-	-	-	-	-
Hemostasis Management, Hospital	$180.43M	$87.45M	$86.42M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Interventional Technologies, Hospital	$118.88M	$56.05M	$59.07M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Plasma	$130.29M	$138.91M	$125.36M	$129.90M	$126.44M	$134.39M	$138.56M	$83.75M	-	-	-	-	-	-	-	-	-	-	-	-
Blood Center	$56.41M	$56.56M	$56.45M	$51.84M	$54.75M	$70.73M	$68.80M	$72.92M	-	-	-	-	-	-	-	-	-	-	-	-
Whole Blood, Blood Center	$17.00K	$389.00K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Service	-	-	-	-	-	-	-	$5.23M	$5.59M	$5.04M	$5.77M	$5.37M	$5.41M	$5.14M	$5.44M	$4.95M	$5.27M	$4.97M	$5.34M	-
Plasma Products and Services	-	-	-	-	-	-	-	-	-	-	-	$153.90M	$143.16M	$118.35M	$116.35M	$102.08M	$90.51M	$123.51M	$97.71M	-
Blood Center Products and Services	-	-	-	-	-	-	-	-	-	-	-	$58.27M	$61.90M	$52.92M	$59.44M	$59.93M	$57.75M	$62.79M	$59.23M	-
Hospital Products and Services	-	-	-	-	-	-	-	-	-	-	-	$93.13M	$92.43M	$90.19M	$83.98M	$77.89M	$80.27M	$54.07M	$52.54M	-

Haemonetics's latest quarterly revenue breakdown by segment (product or service), as of Mar 26: Hemostasis Management, Hospital (23.93%), Hospital (21.18%), Plasma (17.28%), Interventional Technologies, Hospital (15.77%), Apheresis, Blood Center (14.36%), Blood Center (7.48%), and Whole Blood, Blood Center (0.00%).

Haemonetics Revenue Breakdown by Country

Annual Revenue by Country

Country	Mar 26	Mar 25	Mar 24	Apr 23	Apr 22
Europe	$185.02M	$175.66M	$160.14M	$156.68M	$163.52M
Asia	$87.21M	$92.31M	$107.54M	$104.14M	$110.80M
UNITED STATES	$982.18M	$1.01B	$970.01M	$842.90M	$639.32M
Other Country or Region	$11.42M	$19.54M	$13.28M	$3.65M	$3.99M
JAPAN	$68.20M	$62.41M	$58.09M	$61.30M	$75.56M
Plasma	-	-	-	-	$427.61M
Hospital	-	-	-	-	$329.43M
Blood Center	-	-	-	-	$236.16M
Service	-	-	-	-	$20.81M

Haemonetics's latest annual revenue breakdown by geography, as of Mar 26: UNITED STATES (73.62%), Europe (13.87%), Asia (6.54%), JAPAN (5.11%), and Other Country or Region (0.86%).

Quarterly Revenue by Country

Country	Mar 26	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Mar 24	Dec 23	Sep 23	Jul 23	Dec 22	Oct 22	Jul 22	Jan 22	Oct 21	Jul 21	Dec 20	Sep 20	Jun 20
UNITED STATES	-	$730.21M	$482.49M	$242.40M	$248.29M	$257.67M	$256.06M	$245.78M	$250.80M	$236.34M	$237.07M	$224.10M	$211.72M	$182.00M	$167.27M	$152.11M	$141.03M	$147.61M	$123.98M	$111.01M
Other Country or Region	-	$8.31M	$6.50M	$2.81M	$2.77M	$4.94M	$5.27M	$9.15M	$2.65M	$426.00K	$1.06M	$1.09M	$921.00K	$703.00K	$609.00K	$1.03M	$992.00K	$986.00K	$1.04M	$2.33M
Europe	-	$132.12M	$83.85M	$40.88M	$42.28M	$44.16M	$41.99M	$45.05M	$37.03M	$38.67M	$39.39M	$39.10M	$41.85M	$40.46M	$41.54M	$41.18M	$43.34M	$41.87M	$38.65M	$43.02M
JAPAN	-	$49.80M	$31.66M	$13.65M	$16.11M	$16.17M	$16.42M	$16.48M	$14.82M	$15.01M	$11.77M	$15.55M	$15.13M	$13.88M	$19.92M	$18.81M	$17.22M	$20.85M	$19.64M	$16.83M
Asia	-	$67.24M	$44.22M	$21.65M	$21.16M	$25.60M	$25.77M	$26.83M	$30.93M	$27.73M	$22.04M	$25.45M	$27.86M	$24.42M	$30.43M	$26.77M	$25.95M	$29.05M	$26.17M	$22.38M

Haemonetics Peer Comparison by Revenue

Ticker	Company	Last Year Revenue	Last Quarter Revenue
BHC	Bausch Health Companies	$10.16B	$912.00M
XRAY	DENTSPLY SIRONA	$3.68B	$880.00M
QDEL	QuidelOrtho	$2.73B	$699.90M
CON	Concentra Group Parent	$2.16B	$569.55M
ITGR	Integer	$1.85B	$439.58M
HAE	Haemonetics	$1.33B	$338.97M
WRBY	Warby Parker	$871.90M	$242.45M
CPRX	Catalyst Pharmaceuticals	$588.99M	$149.39M
LMAT	LeMaitre Vascular	$249.60M	$61.05M
BEAM	Beam Therapeutics	-	-

HAE Revenue FAQ

What is Haemonetics’s yearly revenue?

Haemonetics's yearly revenue for 2026 was $1.33B, representing a decrease of -1.97% compared to 2025. The company's yearly revenue for 2025 was $1.36B, representing an increase of 3.95% compared to 2024. HAE's yearly revenue for 2024 was $1.31B, representing an increase of 12.01% compared to 2023.

What is Haemonetics’s quarterly revenue?

Haemonetics's quarterly revenue for Q3 2026 was $338.97M, a 3.56% increase from the previous quarter (Q2 2026), and a -2.75% decrease year-over-year (Q3 2025). The company's quarterly revenue for Q2 2026 was $327.32M, a 1.84% increase from the previous quarter (Q1 2026), and a -5.27% decrease year-over-year (Q2 2025). HAE's quarterly revenue for Q1 2026 was $321.39M, a -2.78% decrease from the previous quarter (Q4 2025), and a -4.40% decrease year-over-year (Q1 2025).

What is Haemonetics’s revenue growth rate?

Haemonetics's revenue growth rate for the last 3 years (2024-2026) was 1.91%, and for the last 5 years (2022-2026) was 34.32%.

What are Haemonetics’s revenue streams?

Haemonetics's revenue streams in r 26 are Interventional Technologies, Hospital, Whole Blood, Blood Center, Apheresis, Blood Center, Plasma, Blood Center, Hospital, and Hemostasis Management, Hospital. Interventional Technologies, Hospital generated $234.01M in revenue, accounting 10.92% of the company's total revenue Whole Blood, Blood Center generated $406K in revenue, accounting 0.02% of the company's total revenue Apheresis, Blood Center generated $220.86M in revenue, accounting 10.30% of the company's total revenue Plasma generated $524.46M in revenue, accounting 24.47% of the company's total revenue, down -2.05% year-over-year. Blood Center generated $221.27M in revenue, accounting 10.32% of the company's total revenue, down -15.26% year-over-year. Hospital generated $588.3M in revenue, accounting 27.44% of the company's total revenue, up 4.26% year-over-year. Hemostasis Management, Hospital generated $354.3M in revenue, accounting 16.53% of the company's total revenue

What is Haemonetics’s main source of revenue?

For the fiscal year ending Mar 26, the largest source of revenue of Haemonetics was Hospital. This segment made a revenue of $588.3M, representing 27.44% of the company's total revenue.